Acquired hemophilia A with sigmoid colon cancer: successful treatment with rituximab followed by sigmoidectomy (Q45885727)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Acquired hemophilia A with sigmoid colon cancer: successful treatment with rituximab followed by sigmoidectomy	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19484333

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19484333

title

Acquired hemophilia A with sigmoid colon cancer: successful treatment with rituximab followed by sigmoidectomy (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19484333

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19484333

main subject

hemophilia

0 references

hemophilia A

0 references

sigmoid colon cancer

1 reference

based on heuristic

inferred from title

acquired hemophilia

1 reference

based on heuristic

inferred from title

rituximab

1 reference

based on heuristic

inferred from title

author name string

Satoshi Ichikawa

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19484333

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19484333

Katsura Kohata

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19484333

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19484333

Yoko Okitsu

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19484333

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19484333

Makiko Suzuki

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19484333

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19484333

Shinji Nakajima

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19484333

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19484333

Minami F Yamada

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19484333

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19484333

Yasushi Onishi

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19484333

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19484333

Joji Yamamoto

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19484333

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19484333

Sozo Suzuki

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19484333

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19484333

Kenichi Ishizawa

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19484333

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19484333

Junichi Kameoka

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19484333

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19484333

Hideo Harigae

series ordinal

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19484333

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19484333

publication date

30 May 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19484333

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19484333

published in

International Journal of Hematology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19484333

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19484333

volume

90

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19484333

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19484333

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19484333

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19484333

page(s)

33-36

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19484333

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19484333

cites work

Low response to high-dose intravenous immunoglobulin in the treatment of acquired factor VIII inhibitor

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19484333

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibitors against factor VIII in patients with cancer. Analysis of 41 patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19484333

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19484333

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19484333

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclosporine treatment of acquired hemophilia due to factor VIII antibodies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19484333

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19484333

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acquired factor VIII inhibitors: pathophysiology and treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19484333

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19484333

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19484333

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acquired factor VIII inhibitors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19484333

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S12185-009-0347-9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19484333

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19484333

Dimensions Publication ID

1016776884

0 references

PubMed publication ID

19484333

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19484333

retrieved

17 December 2017

reference URL

http://europepmc.org/abstract/MED/19484333

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45885727&oldid=2207420391"